Erica C. VanderPorten
Publications by Year
Research Areas
Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Microtubule and mitosis dynamics, Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways
Most-Cited Works
- → Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenase(2013)90 cited
- → The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model(2009)84 cited
- → Quantitative Determination of Protein–Ligand Affinity by Size Exclusion Chromatography Directly Coupled to High-Resolution Native Mass Spectrometry(2018)63 cited
- → Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase(2013)60 cited
- → Differential Effects of Divalent Manganese and Magnesium on the Kinase Activity of Leucine-Rich Repeat Kinase 2 (LRRK2)(2010)46 cited
- → Identification of potent, selective KDM5 inhibitors(2016)44 cited
- → Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase(2014)44 cited
- → Aminoisoxazoles as Potent Inhibitors of Tryptophan 2,3-Dioxygenase 2 (TDO2)(2018)40 cited
- → Label-free high-throughput assays to screen and characterize novel lactate dehydrogenase inhibitors(2013)34 cited
- → Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors(2008)31 cited